Integrins and Caspase 8 in Tumor Progression
Integrins and Caspase 8 in Tumor Progression
批准号:
8463126
负责人:
Dwayne G Stupack
金额:
$28.32万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-12-06 至 2015-04-30
关键词:
AdhesionsAdultAntigen ReceptorsApoptosisApoptoticBindingBiochemicalBirdsBlood VesselsCarcinomaCaspaseCatalytic DomainCell SurvivalCell-Cell AdhesionCellsCessation of lifeChildClinicalClinical TrialsCommitComplementComplexDevelopmentDisease ProgressionDown-RegulationEpithelialExhibitsExtracellular MatrixExtracellular Matrix ProteinsFocal AdhesionsFundingGenesGeneticGoalsHomologous GeneHumanImmuneIn VitroIntegrinsLigationLinkMalignant NeoplasmsMammalsMapsMass Spectrum AnalysisMediatingMethylationMolecularMusNeoplasm MetastasisNeuroblastomaNeuroendocrine TumorsPathway interactionsPhosphorylationPhosphorylation SitePlayPre-Clinical ModelProteinsRegulationResistanceRiskRoleSignal TransductionSiteSolid NeoplasmSolventsTestingToll-like receptorsTyrosineTyrosine PhosphorylationUp-Regulationcaspase-10caspase-8cell motilitygene functionin vivomigrationoncologypreventprotein protein interactionreceptortherapy designtumortumor growthtumor progression
中文摘要
Caspase 8和整合素在肿瘤进展中的作用
在上一个资助期,我们证明了半胱天冬酶8与未连接的
整合素在体内促进细胞凋亡,并下调半胱天冬酶8或整合素,
神经母细胞瘤促进肿瘤转移。为了说明这些研究中细胞凋亡的作用,我们
自相矛盾的观察结果是,在抗凋亡细胞中,caspase 8的表达
显著增强整合素介导的体外迁移和体内转移。的总目标
因此,该建议是为了了解caspase 8凋亡与非凋亡功能是如何调节的。
caspase 8作为一种启动子,在死亡受体Toll样受体下游触发细胞凋亡
和整联蛋白。它的表达在侵袭性神经母细胞瘤和其他神经母细胞瘤中经常丢失。
神经内分泌肿瘤这促使临床策略寻求恢复或扩大其
表情然而,半胱天冬酶8对于凋亡是不够的,而是需要一个顺应性的下游调节。
半胱天冬酶级联反应。在凋亡受损细胞中,我们提供了caspase 8
表达实际上起到增强肿瘤转移的作用。这一令人惊讶的结果证明,
重新考虑caspase 8的简单上调是普遍有益的概念;相反,
可能会加剧疾病进展。而caspase 8在免疫系统中的非凋亡功能,
和血管区室是已知的,使胱天蛋白酶8发挥这些功能的机制是
没有在这里,我们提供的初步结果表明,增强细胞迁移发生的同时,
caspase 8酪氨酸磷酸化和定位在粘着斑接触后整合素
结扎本提案的目的1将表征特定的caspase 8酪氨酸残基
在粘附过程中磷酸化,并确定那些关键的迁移。AIM 2将评估哪些
酪氨酸残基影响caspase 8催化和促凋亡活性,包括蛋白质-蛋白质
交互.最后,AIM 3将测试这些调节性酪氨酸残基对疾病的影响
体内进展。总之,这些研究的结果将揭示
半胱天冬酶8调节对于抗转移疗法的发展是重要的。
英文摘要
Caspase 8 and Integrins in Tumor Progression
During the previous funding period, we demonstrated that caspase 8 association with unligated
integrins in vivo promoted apoptosis, and that down-regulation of caspase 8 or integrins in
neuroblastoma promoted tumor metastasis. Confirming the roll of apoptosis in these studies, we made
the paradoxical observation that, among apoptosis-resistant cells, the expression of caspase 8
significantly enhanced integrin-mediated migration in vitro and metastasis in vivo. The overall goal of
this proposal is therefore to understand how caspase 8 apoptotic vs nonapoptotic function is regulated.
As an initiator caspase, caspase 8 triggers apoptosis downstream of death receptors, toll-like receptors
and integrins. Its expression is frequently lost among aggressive neuroblastoma and other
neuroendocrine tumors. This has prompted clinical strategies seeking to restore or amplify its
expression. However, caspase 8 is not sufficient for apoptosis, but requires a compliant downstream
caspase cascade. Among apoptosis-compromised cells, we provide evidence that caspase 8
expression actually functions to enhance tumor metastasis. This surprising result warrants
reconsideration of the concept that simple upregulation of caspase 8 is universally beneficial; rather, it
may exacerbate disease progression. While nonapoptotic functions of caspase 8 within the immune
and vascular compartments are known, the mechanisms committing caspase 8 to these functions are
not. Here, we provide preliminary results showing that enhanced cell migration occurs concurrent with
caspase 8 tyrosine phosphorylation and localization in focal adhesion contacts following integrin
ligation. AIM 1 of this proposal will characterize the specific caspase 8 tyrosine residues
phosphorylated during adhesion, and identify those critical for migration. AIM 2 will evaluate which
tyrosine residues influence caspase 8 catalytic and proapoptotic activities, including protein-protein
interactions. Finally, AIM 3 will test the impact of these regulatory tyrosine residues on disease
progression in vivo. Together, the results of these studies will reveal molecular mechanisms of
caspase 8 regulation important for the development of anti-metastatic therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Smart Nanoplatforms for Multimode Imaging
-
批准号:7490288
-
项目类别:
-
资助金额:$13.35万
-
财政年份:2008
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Neuroblastoma Progression
-
批准号:7152504
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Tumor Progression
-
批准号:8841170
-
项目类别:
-
资助金额:$2.59万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Neuroblastoma Progression
-
批准号:7540471
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Tumor Progression
-
批准号:8096682
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Tumor Progression
-
批准号:8270366
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Tumor Progression
-
批准号:7985022
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Neuroblastoma Progression
-
批准号:7318878
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Tumor Progression
-
批准号:8665527
-
项目类别:
-
资助金额:$6.12万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Neuroblastoma Progression
-
批准号:7085276
-
项目类别:
-
资助金额:$20.09万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Neuroblastoma Progression
-
批准号:6873379
-
项目类别:
-
资助金额:$13.84万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Tumor Progression
-
批准号:8657821
-
项目类别:
-
资助金额:$29.22万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Integrins and Caspase 8 in Neuroblastoma Progression
-
批准号:6989087
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2004
-
负责人:Dwayne G Stupack
-
依托单位:
Targeted Smart Nanoplatforms for Multimode Imaging
-
批准号:8379722
-
项目类别:
-
资助金额:$14.72万
-
财政年份:--
-
负责人:Dwayne G Stupack
-
依托单位:
Targeted Smart Nanoplatforms for Multimode Imaging
-
批准号:8132588
-
项目类别:
-
资助金额:$23.0万
-
财政年份:--
-
负责人:Dwayne G Stupack
-
依托单位:
Targeted Smart Nanoplatforms for Multimode Imaging
-
批准号:7935244
-
项目类别:
-
资助金额:$20.86万
-
财政年份:--
-
负责人:Dwayne G Stupack
-
依托单位:
Targeted Smart Nanoplatforms for Multimode Imaging
-
批准号:8329000
-
项目类别:
-
资助金额:$15.82万
-
财政年份:--
-
负责人:Dwayne G Stupack
-
依托单位:
海外基金